Howland Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6M Sell
46,776
-702
-1% -$394K 0.89% 32
2026
Q1
$26.7M Buy
47,478
+1,166
+3% +$748K 1.05% 29
2025
Q4
$31.3M Sell
46,312
-339
-0.7% -$231K 1.19% 22
2025
Q3
$29.8M Sell
46,651
-449
-1% -$273K 1.14% 27
2025
Q2
$25.3M Sell
47,100
-782
-2% -$374K 1.03% 34
2025
Q1
$20.1M Sell
47,882
-2,083
-4% -$904K 0.9% 39
2024
Q4
$20.7M Buy
49,965
+111
+0.2% +$48.7K 0.9% 36
2024
Q3
$25.2M Buy
49,854
+87
+0.2% +$42.3K 1.09% 29
2024
Q2
$24.2M Sell
49,767
-331
-0.7% -$166K 1.16% 27
2024
Q1
$27M Sell
50,098
-10
-0% -$5.46K 1.31% 23
2023
Q4
$27.8M Sell
50,108
-1,080
-2% -$507K 1.47% 20
2023
Q3
$22.4M Sell
51,188
-3,252
-6% -$1.62M 1.31% 20
2023
Q2
$27.3M Sell
54,440
-611
-1% -$293K 1.57% 19
2023
Q1
$27.5M Sell
55,051
-6,345
-10% -$3.04M 1.66% 17
2022
Q4
$25M Sell
61,396
-1,087
-2% -$422K 1.54% 17
2022
Q3
$20.4M Sell
62,483
-472
-0.7% -$173K 1.31% 27
2022
Q2
$22.1M Sell
62,955
-5,695
-8% -$2.32M 1.36% 29
2022
Q1
$37.6M Sell
68,650
-1,321
-2% -$695K 2.02% 11
2021
Q4
$46.1M Sell
69,971
-11,698
-14% -$7.34M 2.34% 10
2021
Q3
$50.8M Sell
81,669
-21,377
-21% -$14.4M 2.67% 8
2021
Q2
$65.1M Sell
103,046
-7,803
-7% -$4.31M 3.36% 3
2021
Q1
$54.2M Sell
110,849
-6,744
-6% -$3.38M 3.02% 3
2020
Q4
$58.8M Sell
117,593
-2,098
-2% -$939K 3.45% 3
2020
Q3
$47.1M Sell
119,691
-3,118
-3% -$1.15M 3.1% 5
2020
Q2
$40.5M Sell
122,809
-4,707
-4% -$1.36M 2.91% 5
2020
Q1
$30.9M Buy
127,516
+1,676
+1% +$437K 2.71% 5
2019
Q4
$32.9M Buy
125,840
+655
+0.5% +$173K 2.33% 8
2019
Q3
$34M Sell
125,185
-14,216
-10% -$3.96M 2.58% 6
2019
Q2
$38.4M Sell
139,401
-1,652
-1% -$407K 2.97% 6
2019
Q1
$31.5M Sell
141,053
-18,039
-11% -$3.72M 2.57% 6
2018
Q4
$29.6M Sell
159,092
-19,989
-11% -$4.1M 2.78% 4
2018
Q3
$44.7M Sell
179,081
-4,734
-3% -$1.15M 3.39% 2
2018
Q2
$40.1M Sell
183,815
-4,201
-2% -$866K 3.19% 3
2018
Q1
$36M Sell
188,016
-3,243
-2% -$599K 2.9% 4
2017
Q4
$29.9M Sell
191,259
-2,300
-1% -$362K 2.39% 5
2017
Q3
$30.1M Sell
193,559
-56
-0% -$8.85K 2.48% 4
2017
Q2
$31.3M Sell
193,615
-8,785
-4% -$1.43M 2.64% 3
2017
Q1
$31.3M Sell
202,400
-51,073
-20% -$7.04M 2.71% 3
2016
Q4
$29.7M Sell
253,473
-5,144
-2% -$587K 2.77% 3
2016
Q3
$29.2M Sell
258,617
-37,108
-13% -$3.91M 2.71% 4
2016
Q2
$27.5M Sell
295,725
-2,723
-0.9% -$234K 2.59% 4
2016
Q1
$23.4M Sell
298,448
-1,883
-0.6% -$136K 2.38% 6
2015
Q4
$21.9M Buy
300,331
+6,737
+2% +$481K 2.22% 7
2015
Q3
$21.8M Buy
293,594
+3,010
+1% +$216K 2.38% 6
2015
Q2
$18.6M Buy
290,584
+40,664
+16% +$2.82M 1.91% 11
2015
Q1
$19.3M Buy
249,920
+932
+0.4% +$72.5K 1.97% 8
2014
Q4
$18.5M Buy
248,988
+4,000
+2% +$281K 1.84% 15
2014
Q3
$14.4M Sell
244,988
-1,820
-0.7% -$115K 1.48% 21
2014
Q2
$16.5M Buy
246,808
+7,800
+3% +$496K 1.68% 14
2014
Q1
$14.5M Buy
239,008
+20,702
+9% +$1.23M 1.65% 16
2013
Q4
$11.6M Buy
218,306
+7,560
+4% +$398K 1.44% 25
2013
Q3
$10.5M Buy
210,746
+4,460
+2% +$214K 1.43% 26
2013
Q2
$9.25M Buy
+206,286
New +$9.01M 1.46% 23

Other funds holding IDXX

Howland Capital Management's IDXX Position: Q2 2026 in Review

Howland Capital Management reduced its Idexx Laboratories (IDXX) stake by 1.5% in Q2 2026, selling an estimated $394K and leaving 46,776 shares worth $24.6M. The position accounts for 0.89% of the portfolio, ranked #32.

Howland Capital Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $65.1M in Q2 2021. 177 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Howland Capital Management held 46,776 shares of Idexx Laboratories worth $24.6M as of Q2 2026.
  • Howland Capital Management sold 702 Idexx Laboratories shares in Q2 2026, an estimated $394K.
  • Idexx Laboratories made up 0.89% of Howland Capital Management's portfolio in Q2 2026, its #32 holding.
  • Howland Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Howland Capital Management's Idexx Laboratories position peaked at $65.1M in Q2 2021.
  • 177 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.